130 related articles for article (PubMed ID: 20623942)
21. [Staged pain therapy plan. Opioid patch for chronic pain].
MMW Fortschr Med; 2002 May; Suppl 2():71. PubMed ID: 12070857
[No Abstract] [Full Text] [Related]
22. Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination.
Iconomou G; Viha A; Vagenakis AG; Kalofonos HP
Anticancer Res; 2000; 20(6C):4821-4. PubMed ID: 11205226
[TBL] [Abstract][Full Text] [Related]
23. [Fentanyl-TTS in the treatment of pain caused by arthrosis].
Theodoridis T; Waap I; Schwalen S; Krämer J
Z Orthop Ihre Grenzgeb; 2003; 141(2):217-22. PubMed ID: 12695960
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of pain with opioid analgesics and the role of TTS-fentanyl (Durogesic)].
Persoli-Gudelj M
Reumatizam; 2001; 48(2):29-33, 36-7. PubMed ID: 12476746
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics, analgesic effect, and tolerability of a single preprocedural dose of intranasal fentanyl in patients undergoing drain removal after breast reduction or augmentation surgery: A prospective, randomized, double-blind, placebo-controlled study.
Veldhorst-Janssen NM; Fiddelers AA; van der Kuy PH; Kessels AG; Theunissen HM; van der Hulst RR; Neef C; Marcus MA
Clin Ther; 2010 Jul; 32(7):1427-36. PubMed ID: 20678689
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain.
Lorvidhaya V; Katanyoo K; Srisomboon J; Suprapaphorn P; Cheewakriangkrai C
J Med Assoc Thai; 2004 Mar; 87(3):319-25. PubMed ID: 15117050
[TBL] [Abstract][Full Text] [Related]
27. Long-term safety and tolerability of fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic pain: an 18-month study.
Fine PG; Messina J; Xie F; Rathmell J
J Pain Symptom Manage; 2010 Nov; 40(5):747-60. PubMed ID: 20594801
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic pain.
Ashburn MA; Slevin KA; Messina J; Xie F
Anesth Analg; 2011 Mar; 112(3):693-702. PubMed ID: 21304148
[TBL] [Abstract][Full Text] [Related]
29. The use of transdermal fentanyl in cancer pain--a compliance study of outpatients in Taiwan.
Chiou TJ; Liu CY; Tzeng WF; Su YC; Weng YC; Hung CJ; Tang Y; Chen YJ;
Am J Hosp Palliat Care; 2010 Feb; 27(1):31-7. PubMed ID: 19801533
[TBL] [Abstract][Full Text] [Related]
30. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
Sittl R; Nuijten M; Nautrup BP
Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of chronic pain--use of transdermal fentanyl (Durogesic TTS)].
Babić-Naglić D; Jajić Z; Gnjidić Z; Stambuk B
Reumatizam; 2002; 49(2):33-7. PubMed ID: 12476759
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
[TBL] [Abstract][Full Text] [Related]
33. Long-term dosing, safety, and tolerability of fentanyl buccal tablet in the management of noncancer-related breakthrough pain in opioid-tolerant patients.
Nalamachu SR; Narayana A; Janka L
Curr Med Res Opin; 2011 Apr; 27(4):751-60. PubMed ID: 21288055
[TBL] [Abstract][Full Text] [Related]
34. Utilisation pattern of fentanyl transdermal system in The Netherlands.
Breekveldt-Postma NS; Penning-van Beest FJ; Herings RM
Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):129-34. PubMed ID: 15386723
[TBL] [Abstract][Full Text] [Related]
35. Management of cancer-related pain with transdermal fentanyl.
Leelanuntakit S
J Med Assoc Thai; 1996 Jun; 79(6):341-6. PubMed ID: 8855606
[TBL] [Abstract][Full Text] [Related]
36. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.
Berliner MN; Giesecke T; Bornhövd KD
Clin J Pain; 2007; 23(6):530-4. PubMed ID: 17575494
[TBL] [Abstract][Full Text] [Related]
37. [Paradigm change in therapy of moderate chronic opioid responsive pain. Fentanyl alternative to weak opioids].
Riem L
MMW Fortschr Med; 2004 Dec; 146(49):57. PubMed ID: 15646723
[No Abstract] [Full Text] [Related]
38. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer].
Oztürk T; Karadibak K; Catal D; Cakan A; Tugsavul F; Cirak K
Agri; 2008 Jul; 20(3):20-5. PubMed ID: 19085178
[TBL] [Abstract][Full Text] [Related]
39. [Research from the Palliative Care Department in Poznań on treatment of neoplasm pain with Durogesic (transdermal fentanyl)].
Leppert W; Luczak J; Gorzelińska L; Kozikowska J
Przegl Lek; 2000; 57(1):59-64. PubMed ID: 10907375
[TBL] [Abstract][Full Text] [Related]
40. Using high-dose fentanyl patches.
Lilley LL; Guanci R
Am J Nurs; 1996 Jul; 96(7):18-20, 22. PubMed ID: 8659562
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
